Intervention not reported
Rate of positive results found by RAT among airline employees in the USA Random tests were conducted by certified technicians using National Highway Traffic Safety Administration approved devices according to the US Department of Transportation Pr... · Workers in positions with safety‐sensitive functions, other than commercial drivers
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Clinical severity score (CSS) (RDAI score; range 0 to 17; higher = poorer outcomes) measured at 0 to 24 hoursafter treatment · children up to 12 months old with acute bronchiolitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical severity score (CSS) (RDAI score; range 0 to 17; higher = poorer outcomes) measured 25 to 48 hoursafter treatment · children up to 12 months old with acute bronchiolitis
It is very uncertain whether magnesium sulphate changes clinical severity score (CSS) (RDAI score; range 0 to 17; higher =… compared with hypertonic saline (very low certainty).
1 finding from 1 review
Clinical severity score (CSS) (Wang score; range 0 to 12; higher = poorer outcome) measured at 0 to 24 hoursafter treatment · children from 1 month to 24 months old with acute bronchiolitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical severity score (CSS) (Wang score; range 0 to 12; higher = poorer outcome) measured 25 to 48 hoursafter treatment · children from 1 month to 24 months old with acute bronchiolitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical severity score (CSS) (RDAI score; range 0 to 17; higher = poorer outcomes) measured at 0 to 24 hoursafter treatment · children up to 12 months old with acute bronchiolitis
It is very uncertain whether magnesium sulphate + epinephrine changes clinical severity score (CSS) (RDAI score; range 0 to 17; higher =… compared with no treatment or normal saline + epinephrine (very low certainty).
1 finding from 1 review
Clinical severity score (CSS) (RDAI score; range 0 to 17; higher = poorer outcomes) measured 25 to 48 hoursafter treatment · children up to 12 months old with acute bronchiolitis
It is very uncertain whether magnesium sulphate + epinephrine changes clinical severity score (CSS) (RDAI score; range 0 to 17; higher =… compared with no treatment or normal saline + epinephrine (very low certainty).
1 finding from 1 review
Clinical severity score (CSS) (Wang score; range 0 to 12; higher = poorer outcome) measured at 0 to 24 hoursafter treatment · children up to 18 months old with acute bronchiolitis
It is very uncertain whether magnesium sulphate changes clinical severity score (CSS) (Wang score; range 0 to 12; higher =… compared with placebo (very low certainty).
1 finding from 1 review
Clinical severity score (CSS) (Wang score; range 0 to 12; higher = poorer outcome) measured 25 to 48 hoursafter treatment · children up to 18 months old with acute bronchiolitis
It is very uncertain whether magnesium sulphate changes clinical severity score (CSS) (Wang score; range 0 to 12; higher =… compared with placebo (very low certainty).
1 finding from 1 review
Quality of care (Proportion of women receiving high quality cared) · mothers delivering in the hospitals
Maternal death review and audit as part of an intervention package… probably leads to higher quality of care (Proportion of women receiving high quality cared) compared with no intervention (moderate certainty).
1 finding from 1 review
Quality of care for women with complications (Proportion of women with eclampsia or postpartum haemorrhage receiving high quality cared) · mothers delivering in the hospitals
Maternal death review and audit as part of an intervention package… may leads to higher quality of care for women with complications (Proportion of women… compared with no intervention (low certainty).
1 finding from 1 review
Intervention not reported
Self‐efficacy score Scale: Generalized Self‐Efficacy Scale Direction: higher better · women aged 16 years and older who self‐report previous or current experience of intimate partner violence
1 finding from 1 review
Intervention not reported
Safety planning and/or safety behaviour score Service use and activities questionnaire Direction: higher better · women aged 16 years and older who self‐report previous or current experience of intimate partner violence
1 finding from 1 review
Participants' quality of life Measured by EQ‐5D and KCCQ. Higher scores indicate high‐quality of life. · people with heart failure with or without their surrogate decision‐makers/carers
1 finding from 1 review
Participants' depression Measured on PHQ‐8, PHQ‐9, and HADS. Higher scores indicate high depression · people with heart failure with or without their surrogate decision‐makers/carers
1 finding from 1 review
Quality of communication Measured on Quality of Patient‐Clinician Communication About End‐of‐Life Care. Higher score indicates high satisfaction with the quality of communication Assessed after intervention · people with heart failure with or without their surrogate decision‐makers/carers
1 finding from 1 review
no estimate extracted
1 study · 9 participants
Very low
Blood lead levels (high baseline levels) (µg/dL at medium‐term · workers and foremen
2 findings from 1 review
no estimate extracted
18 participants
Very low
no estimate extracted
34 participants
Very low
Blood lead levels (high baseline levels) (µg/dL at long‐term · workers and foremen
1 finding from 1 review
no estimate extracted
69 participants
Very low
Urine lead levels (high baseline levels) (µg/L at short‐term · workers and foremen
1 finding from 1 review
no estimate extracted
35 participants
Very low
Activity Gross motor function · children with cerebral palsy classified within GMFCS Levels I to V and between 3 and 18 years of age
1 finding from 1 review